David Goodman Jr., MD, MAS

David Goodman Jr., MD, MAS

Infectious Diseases

About

Dr. Goodman-Meza is a Mexican-American physician-scientist with a clinical and research interest at the intersection of substance use, addiction, and infectious diseases. His research evaluates the impact of substance use on the treatment and prevention of infectious diseases. His goal is to ultimately improve clinical outcomes in people who use substances.

Languages

English

Education

Medical Board Certifications

Infectious Disease, American Board of Internal Medicine, 2018
Internal Medicine, American Board of Internal Medicine, 2016

Fellowship

UCLA School of Medicine, 2018

Residency

Jacobi Medical Center, 2016

Internship

Jacobi Medical Center, 2014

Degrees

UC San Diego Graduate Division, MAS, 2013
Autonomous University of Baja California, MD, 2011

Hospital Affiliations

Ronald Reagan UCLA Medical Center

UCLA Santa Monica Medical Center

Areas of Focus

Hiv prevention
Suboxone treatment
Opiate addiction

Videos

Scientific and Clinical Perspectives on Cannabis Use - Q & A with UCLA
Facts about Heroin, Fentanyl, and Other Opioids (Spanish-language version)
Facts About Cocaine (Spanish-language version)

Research

Interests

harm reduction, people who inject drugs, buprenorphine, opioid use disorder, HIV prevention

In the News

Is the opioid epidemic coming to Mexico? The Spanish language version of Medscape, the U.K.'s Daily Mail, MedicalXpress, Science Daily, Earth.com, and six other outlets reported on research led by Dr. David Goodman-Meza suggesting that national and international factors could lead to a jump in opioid use and addiction in Mexico. Some of these factors may have their origins in the United States, the researchers said. Goodman-Meza, clinical instructor in the UCLA Division of Infectious Diseases, was quoted. Read more: An opioid epidemic may be looming in Mexico -- and the US may be partly responsible